Momentum showed no signs of slowing on Day 3 of GITEX GLOBAL 2025, with the world’s largest tech and AI event continuing to unveil award-winning breakthroughs, impactful partnerships and powerful use-cases redefining industries. The programme spanned every corner of the technology landscape – from AI and cloud computing to cybersecurity, data centres, robotics, and quantum systems – while a special spotlight on biotech and digital healthcare captured the imagination of audiences with life-changing innovations at the intersection of science and technology.

Also Read: DoH-Abu Dhabi to showcase AI-powered healthcare breakthroughs at GITEX Global 2025

Taking place until Friday, 17 October 2025, the 45th edition of GITEX GLOBAL converges more than 6,800 exhibitors, 2,000 startups, 1,200 investors, and delegations from over 180 countries at Dubai World Trade Centre.

AI and Biotech Converge to Redefine the Future of Health

On the main stage, Trevor Martin, CEO and Co-Founder of Mammoth Biosciences, sparked new digital healthcare ideas with Synthetic Biology: A World Without Disease and Superhuman Possibilities. Martin shared how AI and CRISPR are “rewriting the code of life” to eradicate disease through AI-driven diagnostics and gene-editing technologies. Trevor mentioned: “We have over 8 programs across liver, muscle, the brain, where we’re actively working on curing genetic diseases using this method of changing the DNA. We’re starting now with more rare diseases, but there’s no reason that we have to stop there. Imagine how many millions of lives this could save.”

In a discussion on Decoding Thought: AI and Neurotech Restoring Human Connection, Matt Angle, CEO of Paradromics, talked about a major milestone in medical history – the world’s first successful brain-computer implant and how the technology records neural activity to support patients. Matt noted: “In our clinical trials, we’re trying to enable people who can’t speak to speak. We put the device in an area of their motor cortex … and when you have a high data brain computer interface, you can just try to speak, and it turns into speech right away.”

In “Genomics Beyond Humans: Unlocking Evolution’s Drug Library,” Ashley Zehnder, CEO of Fauna Bio, revealed how decoding the genomes of resilient animal species could uncover an untapped library of new drug discoveries. Ashley explained: “We’re really just hitting the tip of the iceberg in terms of what we can learn about natural adaptation across the world. Animals like the spiny mouse that can regenerate many different tissues in the body, spinal cord, brain kidney, we can learn from these species.”

Click here to join our WhatsApp channel here

Jack Hidary, CEO of SandboxAQ, presented how quantum algorithms could shrink pharmaceutical R&D cycles from decades to months, and dramatically lower drug development costs. Jack stated: “A Large Quantitative Model or LQM is not built on words from the internet but the numbers, equations, molecules and atoms, and they are trained a different way. We’ve built a virtual simulator for the smallest of small atoms, so you can test it millions of times, fast.”

Continuing the healthcare dialogues, two leading sector titans, Dimitris Moulavasilis, Group CEO of M42 and Dr. Georges-Pascal Haber, CEO of Cleveland Clinic, unpacked The $10 Trillion Transition: From Sick Care to Health Intelligence, calling for reimagining healthcare, data science, and digital infrastructure. Dimitris Moulavasilis, Group CEO of M42, shared, “Today’s systems are treatment-oriented, hospital-centric and heavily reactive. Prevention is underfunded. And to build resilient, sustainable, prevention-oriented systems, I think it’s more than moving the investment towards prevention, it’s also redesigning the system all the way, to try to keep patients healthy.”